Bain, Raymond

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy

Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

Cited by 5,394

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffner, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 641

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative

Calis, K. A., Archdeacon, P., Bain, R., DeMets, D., Donohue, M., Elzarrad, M. K., Forrest, A., McEachern, J., Pencina, M. J., Perlmutter, J., et al. (2017) · Clinical Trials

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 58

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29